Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Disfunción endometrial en la diabetes del anciano: influencia de los factores angiogénicos y antiangiogénicos

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 66700
Reference: PI040680
Duration: 01/01/2005 - 28/11/2007

Factores angiogénicos y antiangiogénicos en la retinopatía diabética: cuantificación proteica en humos vítreo y estudio de expresión génica en retina.

IP: Rafael Simó Canonge
Collaborators: José García Arumí, Inés de Torres Ramirez, Cristina Hernández Pascual
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 119000
Reference: SAF2003-00550
Duration: 15/12/2003 - 14/12/2006

Ministerio de Ciencia

Factores angiogénicos, antiangiogénicos y actividad inmunológica en el humor vítreo de los pacientes con retinopatía diabética

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13000
Reference: PRED/IR-HUVH/07/2002
Duration: 01/01/2003 - 31/12/2006

Virus de l´hepatitis C com factor de risc per desenvolupar una diabetes mellitus: estudi dels mecanismes etiopatogènics

IP: Cristina Hernández Pascual
Collaborators: Rafael Simó Canonge, Juan Ignacio Esteban Mur, Joan Genescà Ferrer
Funding agency: Fundació La Marató de TV3
Funding: 41036.17
Reference: TV3/992610
Duration: 01/01/2000 - 31/12/2002

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
López Gutierrez, Pere

López Gutierrez, Pere

Research technician
Cardiovascular Diseases
Read more
Pascual González, Gabriel

Pascual González, Gabriel

Cardiovascular Diseases
Read more
Falcó Roget, Anna

Falcó Roget, Anna

Research technician
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.